Research is a legacyJanuary 5th, 2017
One of the frustrations that comes with being in the medical research space is that it takes time for research breakthroughs to translate into improved care, but we know that research is the only way to leave a legacy for future generations and stop people dying from breast cancer.
When NBCF commissioned an independent audit of the impact of research in 2015, we found that it takes 17 years for the results of a research study to make a difference to patient care, and that more focus is needed to ensure dollars spent on research translate into new treatments and guidelines for care and support.
NBCF funds projects designed to speed up this process and fast-track the
transition of discoveries made in the lab, so they benefit those affected by
breast cancer faster – supporting the bench-to-bedside philosophy.
It’s because of the steps involved – which take time – that the community trusts the treatments they’re prescribed. The ethical framework, check and balances, peer reviews of data and results, lab trials, drug development and refinement, policy and guideline development for usage, and the many phases of human trials needed before a treatment is approved are just some of the steps in an incredibly complicated process to deliver better care to patients.
Funding research kick-starts the process and it’s hoped that in the sooner-rather-than-later future breast cancer and many other cancers and diseases, will become treatable illnesses that no longer kill people.
Donating to the National Breast Cancer Foundation supports the initial phases of the bench-to-bedside philosophy. These funds support researchers who have the potential to bring us a step closer to zero deaths by 2030.
The research we fund, thanks to community donations, leaves a
long-term legacy that will make a life-changing difference for
future generations affected by breast cancer.